Skip to main content
生物谷 logo

生物谷 — Investor Relations & Filings

Ticker · 920266 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2025-09-28 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920266

About 生物谷

https://www.bioon.com/

Bio-Valley specializes in the research, development, and manufacturing of botanical-based therapeutic solutions, with a primary focus on cardiovascular and cerebrovascular health. The company is a leader in the industrialization of Erigeron breviscapus (Dengzhanhua), a botanical resource used for treating ischemic stroke and its sequelae. Its core product portfolio includes Dengzhan Shengmai Capsules and Dengzhan Xixin Injection, which are utilized in clinical settings for their neuroprotective and microcirculation-improving properties. Bio-Valley maintains a comprehensive value chain encompassing botanical cultivation, standardized extraction, and large-scale production. By leveraging advanced extraction technologies and rigorous quality control, the company provides evidence-based solutions for chronic disease management and geriatric care.

Recent filings

Filing Released Lang Actions
2025年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 first extraordinary shareholders meeting of Yunnan Shengwu Valley Pharmaceutical Co., Ltd. It includes information about the meeting date, location, attendance, voting results on various proposals, and legal opinions confirming the validity of the meeting and votes. The content focuses on shareholder voting outcomes and meeting procedures rather than financial results or management commentary. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4015 characters, which is sufficient to contain detailed voting results rather than a brief announcement. Therefore, the correct classification is DVA with high confidence.
2025-09-28 Chinese
公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for 云南生物谷药业股份有限公司, including comprehensive provisions on company organization, shareholder rights, board responsibilities, share issuance, and governance rules. It references Chinese company law, securities law, and stock exchange listing rules. The content is legal and governance-focused, detailing internal rules and procedures rather than financial results or announcements. It is not an announcement, transcript, or report of financial performance but a governance document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2025-09-28 Chinese
职工代表董事任命公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of a new employee representative director to the company's board. It details the election process, compliance with legal and company regulations, and includes a brief biography of the appointed individual. There is no financial data, report, or presentation content. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-09-28 Chinese
董事、高级管理人员持股变动管理制度
Governance Information Classification · 95% confidence The document is titled '董事、高级管理人员持股变动管理制度' which translates to 'Management System for Shareholding Changes of Directors and Senior Management'. It details internal rules and regulations regarding shareholding changes by directors and senior management, including compliance with laws, reporting requirements, restrictions on share transfers, and disclosure obligations. It is a governance-related document focusing on internal policies for managing shareholding changes by key personnel. There is no indication that this is an announcement of a report, a financial report, or a regulatory filing. It is not a report of director's dealing transactions but rather the policy governing such dealings. Therefore, the document fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (4506 characters) and detailed content support this classification with high confidence.
2025-09-10 Chinese
董事、高级管理人员薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled '董事、高级管理人员薪酬管理制度' which translates to 'Remuneration Management System for Directors and Senior Management'. It details the company's policies, principles, and procedures regarding the remuneration of directors and senior management, including salary standards, payment methods, adjustment criteria, and governance structure. It is a detailed report on compensation management rather than an announcement or a brief summary. The document does not contain financial statements or earnings data, so it is not an annual or interim report. It is not a proxy statement or voting result announcement. The content aligns with the definition of Remuneration Information filings, which detail compensation for top executives and directors. The document length is 2916 characters, which is sufficient for a detailed policy document. Therefore, the appropriate classification is 'DEF 14A' (Remuneration Information).
2025-09-10 Chinese
会计师事务所选聘制度
Governance Information Classification · 95% confidence The document is titled '云南生物谷药业股份有限公司 会计师事务所选聘制度' which translates to 'Yunnan Biological Valley Pharmaceutical Co., Ltd. Accounting Firm Selection System'. It details the internal procedures, requirements, and governance related to the selection, appointment, and replacement of the company's accounting firm (auditor). It includes voting results from a board meeting, procedural rules, quality requirements, and supervisory measures. There are no financial statements, audit opinions, or audit reports included. The document is a governance and procedural policy related to audit firm selection rather than an audit report or annual report. It is not a certification or a brief announcement but a detailed internal governance document. Therefore, the best fitting category is Governance Information (CGR). The document length is 4035 characters, which is substantial and contains detailed governance content, not a short announcement or certification.
2025-09-10 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.